Hamilton Lane's Public Offering Impacts Stock Price Ahead of Market Opening
Market Chameleon (Tue, 11-Feb 3:38 AM ET)
Hamilton Lane Announces Pricing of Public Offering of Class A Common Stock
PRNewswire (Mon, 10-Feb 8:15 PM ET)
Hamilton Lane commences underwritten public offering of 1.57M shares
Seeking Alpha News (Mon, 10-Feb 4:39 PM ET)
Hamilton Lane Announces Public Offering of Class A Common Stock
PRNewswire (Mon, 10-Feb 4:22 PM ET)
Cosette Pharmaceuticals Appoints Vincent Colicchio as Senior Vice President of Operations
Business Wire (Mon, 10-Feb 8:00 AM ET)
Morgan Stanley Sticks to Its Hold Rating for Hamilton Lane (HLNE)
TipRanks (Thu, 6-Feb 8:16 AM ET)
PRNewswire (Thu, 6-Feb 7:00 AM ET)
PRNewswire (Tue, 4-Feb 7:00 AM ET)
Cosette Pharmaceuticals Appoints Brad Leonard as Vice President, Generics Commercial Operation
Business Wire (Mon, 3-Feb 8:00 AM ET)
Hamilton Lane Inc is a private market investment solutions provider in the United States. It works with its clients to conceive, structure, build out, manage and monitor portfolios of private markets funds and direct investments, and it helps them access a set of such investment opportunities around the world. The company offers a range of investment solutions across a range of private markets, including private equity, private credit, real estate, infrastructure, natural resources, growth equity, venture capital and impact. The company generate revenues mainly from management and advisory fees.
Hamilton Lane - Class A trades on the NASDAQ stock market under the symbol HLNE.
As of February 11, 2025, HLNE stock price declined to $156.86 with 1,550,589 million shares trading.
HLNE has a beta of 1.22, meaning it tends to be more sensitive to market movements. HLNE has a correlation of 0.24 to the broad based SPY ETF.
HLNE has a market cap of $6.55 billion. This is considered a Mid Cap stock.
Last quarter Hamilton Lane - Class A reported $168 million in Revenue and $1.25 earnings per share. This beat revenue expectation by $10 million and exceeded earnings estimates by $.15.
In the last 3 years, HLNE traded as high as $203.72 and as low as $55.81.
The top ETF exchange traded funds that HLNE belongs to (by Net Assets): IJH, VTI, IWM, VB, VXF.
HLNE has outperformed the market in the last year with a return of +37.0%, while the SPY ETF gained +22.1%. However, in the most recent history, HLNE shares have underperformed the stock market with its stock returning -19.1% in the last 3 month period and -1.1% for the last 2 week period, while SPY has returned +1.5% and +0.9%, respectively.
HLNE support price is $162.76 and resistance is $170.02 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HLNE shares will trade within this expected range on the day.